<p><b>Copyright information:</b></p><p>Taken from "promoter methylation and expression analysis in normal and neoplastic kidney indicates a role in early tumorigenesis"</p><p>http://www.molecular-cancer.com/content/6/1/49</p><p>Molecular Cancer 2007;6():49-49.</p><p>Published online 16 Jul 2007</p><p>PMCID:PMC1939711.</p><p></p>nes of the tumor (T) and normal (P) group analyzed by bisulfite sequencing. For each clone the methylation status of analyzed CpG sites is shown (solid circles: methylation, open circles: no methylation). Numbers on x-axis refer to base pair positions as indicated in Figure 1. Asterisks indicate amplicons derived from densely methylated promoters demonstrating at least 11 methylated CpG sites
WOS: 000268680200019PubMed ID: 19641369Renal cell carcinoma (RCC) is the most common malignancy of t...
Renal cell carcinoma (RCC) is the most common malignancy of the kidney. Since RCC is curable when it...
Abstract Background Renal cell carcinoma accounts for 2–3% of all cancers and metastasis increased t...
<p><b>Copyright information:</b></p><p>Taken from "promoter methylation and expression analysis in n...
<p><b>Copyright information:</b></p><p>Taken from "promoter methylation and expression analysis in n...
<p><b>Copyright information:</b></p><p>Taken from "promoter methylation and expression analysis in n...
<p><b>Copyright information:</b></p><p>Taken from "promoter methylation and expression analysis in n...
<p><b>Copyright information:</b></p><p>Taken from "promoter methylation and expression analysis in n...
<p><b>Copyright information:</b></p><p>Taken from "promoter methylation and expression analysis in n...
Abstract Background Aberrant promoter hypermethylation of cancer-associated genes occurs frequently ...
The majority of renal cell carcinoma (RCC) is now incidentally detected and presents as small renal ...
The majority of renal cell carcinoma (RCC) is now incidentally detected and presents as small renal ...
<div><p>The majority of renal cell carcinoma (RCC) is now incidentally detected and presents as smal...
Promoter region hyermethylation and transcriptional silencing is a frequent cause of tumour suppress...
Renal cell carcinoma (RCC) is the most common malignancy of the kidney. Since RCC is curable when it...
WOS: 000268680200019PubMed ID: 19641369Renal cell carcinoma (RCC) is the most common malignancy of t...
Renal cell carcinoma (RCC) is the most common malignancy of the kidney. Since RCC is curable when it...
Abstract Background Renal cell carcinoma accounts for 2–3% of all cancers and metastasis increased t...
<p><b>Copyright information:</b></p><p>Taken from "promoter methylation and expression analysis in n...
<p><b>Copyright information:</b></p><p>Taken from "promoter methylation and expression analysis in n...
<p><b>Copyright information:</b></p><p>Taken from "promoter methylation and expression analysis in n...
<p><b>Copyright information:</b></p><p>Taken from "promoter methylation and expression analysis in n...
<p><b>Copyright information:</b></p><p>Taken from "promoter methylation and expression analysis in n...
<p><b>Copyright information:</b></p><p>Taken from "promoter methylation and expression analysis in n...
Abstract Background Aberrant promoter hypermethylation of cancer-associated genes occurs frequently ...
The majority of renal cell carcinoma (RCC) is now incidentally detected and presents as small renal ...
The majority of renal cell carcinoma (RCC) is now incidentally detected and presents as small renal ...
<div><p>The majority of renal cell carcinoma (RCC) is now incidentally detected and presents as smal...
Promoter region hyermethylation and transcriptional silencing is a frequent cause of tumour suppress...
Renal cell carcinoma (RCC) is the most common malignancy of the kidney. Since RCC is curable when it...
WOS: 000268680200019PubMed ID: 19641369Renal cell carcinoma (RCC) is the most common malignancy of t...
Renal cell carcinoma (RCC) is the most common malignancy of the kidney. Since RCC is curable when it...
Abstract Background Renal cell carcinoma accounts for 2–3% of all cancers and metastasis increased t...